Dr. Sridhar on long-term follow-up from the JAVELIN Bladder 100 trial
March 14th 2023Regardless of the type of chemotherapy regimen received, there was a benefit with the use of frontline avelumab maintenance in patients with locally advanced or metastatic urothelial carcinoma, explains Srikala S. Sridhar, MD.
Dr. Bukavina and Dr. Psutka share take-homes from kidney cancer epidemiology paper
November 25th 2022“We need to continue to push the field forward, and the way we do that is to evaluate the risk factors and to stratify patients based on their risk factors and their genetic components,” says Laura Bukavina, MD, MPH.
Expert Forum: Fertility after exogenous testosterone replacement
Treatment of azoospermia after exogenous testosterone use may require aggressive medical therapy, according to Kelli Gross, MD.